Get information on Glucophage | Affordable price - in Australia

Overview section

Metformin, commonly marketed as Glucophage, belongs to the biguanide class and is a mainstay oral treatment for type 2 diabetes. Its primary the underlying mechanisms are to reduce hepatic glucose production, slow intestinal glucose uptake, and enhance peripheral insulin sensitivity in muscle and adipose tissue.

When prescribed alone, metformin seldom causes hypoglycaemia, unlike insulin or certain secretagogues. Many people experience stable or modest weight loss while taking it. Metformin requires some endogenous or supplemental insulin action to work and is not an a different option to consider to insulin treatment for type 1 diabetes.

The active substance is metformin hydrochloride. Common tablet strengths in Australia include immediate-release 250 mg, 500 mg, 850 mg and 1000 mg, and extended-release products such as 500 mg, 750 mg and 1000 mg XR. For urgent situations such as acute illness or radiological proceduresa quick review the important safety notes below and consult your prescriber or the disclaimer statement: Use this information at your own risk and discretion. in the footer (Not for professional advice: heads up: This material is provided as a disclaimer and should not be relied upon.).

Who this item is for

Metformin is widely used in adults with type 2 diabetes, often as first-line pharmacotherapy after lifestyle measures. It may be combined with other glucose-lowering medicines including sulfonylureas, insulin, SGLT2 inhibitors, DPP-4 inhibitors or GLP-1 receptor agonists when additional glycaemic control is needed.

Under specialist direction, metformin is also prescribed off-label for conditions such as polycystic ovary syndrome (PCOS). Use in pregnancy and lactation phase should be decided with your obstetrician or treating clinician registered situated within Australia.

Ways to take and determine the dosing

Take metformin exactly as directed by your prescriber. To reduce gastrointestinal upset, take with a meal. Typical adult regimens include:

• Immediate-release (IR): often initiated at 500 mg twice daily or 850 mg once daily with food, with gradual increases every one to two weeks based on response and tolerance.
• Maximum IR dosing: some patients use up to 2550 mg per day divided across doses, although many achieve control on 1500 to 2000 mg daily.
• Extended-release (XR): usually started at 500 mg to 1000 mg once daily with the main evening meal and titrated up, with many regimens capping around 2000 mg once daily depending on the product.

Do not crush, chew or split extended-release tablets; swallow whole. Your clinician will personalise dosing according to fasting glucose, HbA1c and lingering reactions.

Cautions and general safety protective measures

Although rare, metformin has been linked to lactic acidosis, a potentially life-threatening condition. Stop metformin and seek urgent medical attention if you develop severe weakness, profound fatigue, breathing difficulties, dizziness, very slow or irregular heartbeat, severe abdominal pain, unexplained muscle pain, or fainting.

• Hypoglycaemia: metformin alone rarely causes low blood glucose, but the risk rises when it is combined with insulin, sulfonylureas or other hypoglycaemic agents, or when meals are skipped or alcohol is consumed. Keep rapid-acting carbohydrate available if there is a need.
• Kidney function: suitability and dosing depend on estimated glomerular filtration rate (eGFR). Assess renal function before starting and monitor periodically.
• Contrast studies: pause metformin at or before procedures using iodinated contrast and recheck renal function at least 48 hours after before restarting.
• Major illness or surgery: consider temporary discontinuation during severe infection, dehydration, major operations or any condition that may impair kidney perfusion or oxygen delivery.
• Liquid alcohol: avoid binge or heavy drinking which increases the risk of lactic acidosis and hypoglycaemia.
• Vitamin B12: long-term use may lower B12 levels; test if you develop unexplained neuropathy or anemia.
• Expecting mothers and breastfeeding mothers: treatment plans should be confirmed with your Australian healthcare team; do not alter therapy without advice.

Cases where treatment is not appropriate and situations to avoid

Do not use metformin if any of these apply, unless an Australian prescriber advises otherwise:

• Allergy to metformin or any tablet ingredient.
• Severe renal impairment or acute kidney injury.
• Acute metabolic acidosis including diabetic ketoacidosis, or a history of lactic acidosis.
• Unstable or acute heart failure, recent myocardial infarction, severe respiratory failure, or other causes of significant hypoxia.
• End-stage liver disease or ongoing heavy alcohol misuse.
• Severe dehydration, major infection, recent significant trauma or major surgery.
• Very low calorie diets (for example under 1000 kilocalories per day) where metabolic stress is increased.

As noted above, pause metformin around contrast imaging or major operations. For more on effective the interaction between participantss require clear communication. and lawful access see the effective the interaction between participantss require clear communication. and access sections (subtle collaborative interactions can reinforce culture., lawful ingress).

Possible effects to watch for

The most common unwelcome unintended effects affect the gastrointestinal tract, particularly when treatment is begun or doses are raised. Many of these effects subside with time or after switching to an extended-release formulation.

• Frequent: nausea, vomiting, diarrhea, abdominal discomfort, loss of appetite, bloating, flatulence, metallic taste.
• Occasional: a severe headache, drowsiness, skin rash, itching or hives.
• Rare, but grave.: lactic acidosis (see protective protocols), severe allergic reactions including swelling and breathing problems, or acute fluid retention in heart failure.
• Long term: potential reduction in vitamin B12 levels; check if you develop anemia or neuropathy.

If you have severe or persistent symptoms contact your prescriber or local emergency services immediately.

Potential drug conversational exchange alert effects

Always tell your healthcare team about all prescription medicines, over the counter drugs, herbal products and supplements you use. Principal the quality of interpersonal engagements matters for trust. include:

• Iodinated contrast media: these may increase the risk of kidney injury and lactic acidosis; withhold metformin and confirm renal function before restarting.
• Spirituous beverage: increases the risk of hypoglycaemia and lactic acidosis; avoid excessive intake.
• Cimetidine, the acid reflux remedy: can raise metformin plasma levels; another option antacids or acid suppressants are commonly chosen.
• Agents that raise blood glucose: corticosteroids, some thyroid hormones, certain oral contraceptives, sympathomimetics, thiazide diuretics and niacin can lessen metformin efficacy.
• Agents that lower glucose: combining with insulin, sulfonylureas or some antibiotics may increase hypoglycaemia risk and require dose adjustment.
• Drugs affecting renal function: diuretics and nephrotoxic agents warrant close metric monitoring of renal markers and glucose control.

Look over the tips for missed dosing for what to do if a dose is missed (i skipped the dose).

Dose was missed

If you forget to take your dose, take it with food as soon as you remember unless the next dose is imminent. If the next scheduled dose is close, skip the i did not take the dose and continue as normal. Do not try to catch up on a i did not take the dose by doubling up. Keep a fast-acting carbohydrate source available if you are taking other medications that can cause low blood sugar.

Drug a drug overdose scenario

An overdosed on medication may lead to hypoglycaemia if other antidiabetic drugs are involved and can precipitate lactic acidosis. Symptoms may include extreme drowsiness, confusion, sweating, tremor, fainting, seizures, breathing difficulty, severe abdominal or muscle pain. Seek emergency medical care immediately if an overdosed on medication is suspected.

Object data storage solutions include cloud storage, hard drives, and optical media.

Store metformin at normal room temperature, ideally between 20 to 25 C (68 to 77 F). Protect tablets from moisture, heat and direct sunlight. Do not store in bathrooms. Put medications out of reach of children and pets. Dispose of expired or unused tablets via your pharmacy take-back service or local disposal sound advice.

Other options and similar medications

If metformin is unsuitable or additional glucose lowering is required, Australian prescribers may consider other drug classes. Choice is guided by glycaemic targets, coexisting conditions, side effect profile and cost.

• Sulfonylureas (for example gliclazide, glimepiride): effective and inexpensive but increase hypoglycaemia risk and may cause weight gain.
• SGLT2 inhibitors (for example empagliflozin, dapagliflozin): lower cardiovascular and renal risks in some patients but can raise the chance of genital infections and dehydration.
• DPP-4 inhibitors (for example sitagliptin, linagliptin): generally well tolerated, weight neutral and provide modest glucose lowering.
• GLP-1 receptor agonists (for example semaglutide, dulaglutide): often promote weight loss and have cardiovascular benefits in selected patients; typically injectable, with an oral option available for some agents.
• Insulin: required for type 1 diabetes and often used in advanced type 2 diabetes or severe hyperglycaemia.
• Other choices such as acarbose or pioglitazone may suit selected patients but have specific tolerability or safety risks to assess.

Discuss with your clinician which therapy best matches your medical needs, preferences and whether Pharmaceutical Benefits Scheme (PBS) subsidies apply. Eye the cost section for rough cross vendor cost comparison among brandss (Prices charged in Australia).

Price levels in Australia for the AUD market

Out of pocket costs vary by brand, tablet strength, pack size, pharmacy and PBS eligibility. The figures below are approximate and intended as general guidance only.

• Metformin (generic or branded): on the PBS many people pay the current prescription co-payment; without subsidy a monthly supply of generic metformin may typically cost around AU$5 to AU$30 depending on dose and pack size.
• Sulfonylureas: generally inexpensive and often comparable to metformin generics in price.
• DPP-4 and SGLT2 inhibitors: these are often available on the PBS for selected patients and attract the PBS co-payment when subsidised; private purchase without subsidy may cost over AU$100 per month.
• GLP-1 receptor agonists: private costs are substantially higher than oral agents and PBS access is restricted to defined criteria for eligible patients.

PBS co-payments and subsidy rules change periodically. For exact current prices and whether your prescription qualifies for PBS subsidyinspect the details. with your pharmacist or prescriber.

Legal access and prescribing in Australia

Metformin is a prescription-only medicine (Schedule 4) australian territory. Important points on lawful access include:

• Prescription requirement: a valid prescription from an Australian-registered prescriber such as a GP, specialist or nurse practitioner is required to obtain metformin legally.
• Pharmaceutical Benefits Scheme: many metformin products are listed on the PBS; eligibility for subsidy depends on indication and patient circumstances. Dispensing rules follow PBS and state regulations.
• Telehealth prescribing: is allowed when clinically appropriate and consistent with Australian prescribing guidelines.
• Personal importation: under Therapeutic Goods Administration provisions patients may import a limited personal supply in specific circumstances; documentation from a prescriber is recommended and resale is prohibited.
• Driving and safety: metformin by itself rarely causes hypoglycaemia, but combined use with other hypoglycaemic agents may impair driving or machinery operation; take appropriate protective actions.

For legal or clinical questions contact your prescriber, pharmacist or the relevant health authority. Related information mutual interactions between people can shape outcomes. and protective measures for matters affecting procedures or imaging (the interaction between participantss create context for decisions., cautionary measures).